Title |
Intervention | NCT ID | Sponsor | Status |
|---|---|---|---|---|
| Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment | Quality-of-Life Assessment, Questionnaire Administration | NCT03516942 | ECOG-ACRIN Cancer Research Group | Active, not recruiting |
| Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial... | Exemestane, Laboratory Biomarker Analysis, Pharmacokinetic Study, Questionnaire Administration | NCT03300557 | National Cancer Institute (NCI) | Active, not recruiting |
| Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast... | Biospecimen Collection, Screening Mammography | NCT03609021 | Alliance for Clinical Trials in Oncology | Active, not recruiting |
| Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous... | Erlotinib, Erlotinib Hydrochloride | NCT02961374 | National Cancer Institute (NCI) | Active, not recruiting |
| Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver | Erlotinib, Erlotinib Hydrochloride, Laboratory Biomarker Analysis, Quality-of-Life Assessment | NCT02273362 | National Cancer Institute (NCI) | Active, not recruiting |
| Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure... | Assessment of Therapy Complications, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration | NCT01790152 | Children's Oncology Group | Recruiting |
| Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer | Interview, Questionnaire Administration | NCT03963739 | Wake Forest University Health Sciences | Recruiting |
| Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III... | Duloxetine, Duloxetine Hydrochloride, Oxaliplatin, Placebo, Quality-of-Life Assessment, Questionnaire Administration | NCT04137107 | Alliance for Clinical Trials in Oncology | Recruiting |
| Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American... | Docetaxel, Paclitaxel, Quality-of-Life Assessment, Questionnaire Administration | NCT04001829 | ECOG-ACRIN Cancer Research Group | Recruiting |
| DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection | Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid | NCT02772003 | National Cancer Institute (NCI) | Active, not recruiting |
Why I Joined a Clinical Trial
Living through my sister’s heroic battle with breast cancer and being a woman at high risk, I knew there had to be a better way than “watch and wait”. Prevention became my passion; BCPT my clinical trial to find answers to prevent this disease for my young nieces and all women. Together, through clinical trials, we can prevent breast cancer.